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As in other medical fields, the availabil-
ity of next generation sequencing (NGS)
techniques is about to revolutionize diag-
nostics of infectious diseases. The demon-
stration of the microbial origin of diseases
and their diagnosis were initially based on
the demonstration of the presence of a
given pathogen in a given clinical sample,
and was first dominated by culture assay
for bacteria and later for viruses. These
techniques do not advance prior hypothe-
ses regarding the causative agents except
their cultivability. In order to seek spe-
cific pathogens, specialized media—rich
or selective—and culture conditions—
defined oxygen tension or temperature—
can be used. These techniques suffer
a number of limitations, including the
need for a dedicated specialized staff and
their intrinsic inefficiency in the prop-
agation of fastidious bacteria and sev-
eral major viruses (Treponema palidum,
Mycobacterium leprae, Hepatitis A, B, C
and E viruses). They have been pro-
gressively complemented and sometimes
replaced by nucleic acid-based tests like
PCR or NASBA. The advantages of PCR
are numerous: speed, low cost, automa-
tion, sensitivity, and specificity. The main
drawback of targeted, pathogen-specific
PCR is that it is only able to identify
predefined targets, which supposes that
the physician has elaborated an etiologi-
cal hypothesis. Moreover, for a series of
pathogens, and in particular highly vari-
able RNA viruses like enteroviruses or
DNA viruses such as papillomaviruses
and adenoviruses that comprise multiple
types, PCR-based tests target conserved
loci that do not discriminate between
genotypes.
To bypass these difficulties, several
strategies have been developed, all of
whose main objective is to broaden the
range of detection. Direct hybridization
of non-amplified or random amplified
nucleic acids (NA) from samples on DNA
arrays has not been proven satisfactory,
mostly owing to its relative lack of sensi-
tivity for medical diagnosis. Bacterial typ-
ing can be achieved by sequencing the
16S gene or other regions of the genome
that are sufficiently conserved to allow
definition of consensus primers yet suffi-
ciently variable to allow for typing. Use of
NGS has increased the depth of sequenc-
ing by several orders of magnitude and
thereby the capacity to detect rare species.
Nevertheless, with 16S PCR, the taxo-
nomic assignation remains often at the
level of the genus, an intrinsic limit due
to the conservation of the locus between
species of the same genus.
Multiplexed PCR assays for multiple
loci have been and are still being devel-
oped to provide, at least in principle,
simultaneous detection of several agents.
Amplicons of multiplexed PCRs can be
detected by multiple labeled probes. For
example, LightCycler SeptiFast (LC-SF) is
a real-time multiplex PCR test able to
detect 25 common pathogens responsi-
ble for bloodstream infections. A meta-
analysis of 34 studies enrolling 6012
patients with suspected sepsis demon-
strated an overall sensitivity and speci-
ficity of 0.75 (95% CI: 0.65–0.83) and
0.92 (95%CI: 0.90–0.95), respectively, to
detect bacteremia or fungemia (Chang
et al., 2013). Some multiplex PCR assays
can be restricted to certain syndromes
to limit the range of pathogens to be
tested simultaneously, such as, for exam-
ple, respiratory infections (Dabisch-Ruthe
et al., 2012). The range of multiplex PCR
can be considerably improved by design-
ing primers targeting numerous pathogens
and varied loci within pathogens and
resolving these amplicons using electro-
spray ionization-mass spectrometry (Wolk
et al., 2012) or NGS (Arena et al., 2014).
Nevertheless, detection by ionization-mass
spectrometry is not based on the determi-
nation of the sequence of the amplicon,
in contrast to NGS. Diagnostic kits tar-
geting nosocomial pathogens or influenza
virus are available. It remains to be seen,
however, whether such highly multiplexed
PCRs can be applied to a wide range of
pathogens, some of which are highly vari-
able in sequence, without losing the ana-
lytical sensitivity of single PCR, one of
the major advantages of the technique.
Moreover, the design of numerous primers
will have to be constantly updated along
with increase in the number of sequences
in databases and identification of new
pathogens, in order to maintain a high
range of detection. Indeed, addition of
a new primer pair to an already highly
multiplexed PCR requires some degree of
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revalidation, which can become a labori-
ous and never-ending process.
An alternative strategy takes advantage
of the increasing availability and speed
and decreasing cost per base of NGS
offered by deep sequencing machines. It is
now possible to use the tools of metage-
nomics, which is the study of the microbial
genetic sequences recovered directly from
a given human, animal, or environmen-
tal sample. In this setting, the sequence
of all the NA species of the sample are
determined and compared with those in
databases. This technology has first been
used to describe the complexity and the
dynamics of microbiomes from different
origins, including from the gut, other
mucosal sites and the skin, as well as from
various human-made (e.g., sewage) and
natural (e.g., sea) environments. It has
also been used to discover new infectious
agents. De novo assembly of full length
genomes of pathogens can sometimes be
achieved directly from the samples, and
if not large partial sequences can be sub-
sequently completed by using classical
molecular biology tools. Frequently, such
metagenomic study uncover known but
unexpected viruses, phages, bacteria, par-
asites or fungi (De Vlaminck et al., 2013),
which paves the way to application in the
field of diagnosis of infectious diseases.
As reviewed recently (Barzon et al., 2013;
Capobianchi et al., 2013), some appli-
cations for NGS in virology—pathogen
discovery, study of viral variability—have
already emerged.
In principle, such a whole genome
NGS (WG-NGS) would be advantageous
in clinical diagnostics, as there is no need
to design specific primers to pre-amplify
target sequences. This avoids the very hard
work consisting of designing several tens
or hundreds of specific primers able to
target multiple pathogens, and checking
their capacity to function simultaneously
without interference. Furthermore, there
is no requirement for continuous adapta-
tion of the sequence of primers with the
description of new variants and species.
These advantages, however, come with
several drawbacks. The main one is that
random amplification, currently indis-
pensable for all available sequencing tech-
nologies, also amplifies host NA, meaning
that searching for microbial NA is like
looking for a needle in a haystack. Indeed,
while the depth of sequencing can com-
pensate, at least in part, for this shortcom-
ing, it is not cost-effective. The microbe vs.
host NA ratio must therefore be increased
using different strategies, such as hydrol-
ysis, chemical treatment or depletion of
host sequences. Nevertheless, this proce-
dure still requires high depth sequencing,
at least if an analytical sensitivity simi-
lar to that of diagnostic PCRs is expected.
Also, good genome coverage is necessary
to predict phenotypes such as resistance
to antimicrobials or virulence, as loci of
interest are not specifically targeted and
success in obtaining the necessary genetic
information is unpredictable when partial
sequences are acquired.
The analytical sensitivity of WG-NGS
is not as easy to evaluate as that of
PCR, as it is more critically influenced
by matrix properties. In particular, the
quantity of host NA, as well as its physi-
cal state or association with proteins, may
complicate its elimination before sequenc-
ing. Also, the analytical sensitivity criti-
cally depends on the depth of sequencing.
Using around 20,000–100,000 reads of the
454 platform per sample, only a high load
of the Schmallenberg virus (superior to
1010 gc/mL) could be detected in clinical
samples (Rosseel et al., 2012). Increasing
the depth of sequencing for an opti-
mized sample preparation can decrease the
level of detection down to 102–103 gc/mL,
within the range of most homemade
PCRs. Also, in contrast to PCR, the ana-
lytical sensitivity depends on the length
of the genome. Longer length translates
into a higher number of potentially avail-
able reads as seen in some studies for
viruses (Wylie et al., 2012). This should
also be the case for bacterial and fungal
genomes, which could be seen as an advan-
tage for the detection of such microbes
as their blood concentration can be very
low even in samples of infected patients.
The diagnostic sensitivity was evaluated
in some studies. Sequence analysis of the
human virome in febrile and afebrile chil-
dren revealed a wide range of viruses in
plasma that correlated with the febrile
status (Wylie et al., 2012). Of note, this
study illustrated that compared with PCR,
WG-NGS missed some samples found
positive with high CT by qPCR, a short-
coming that was partially overcome by
increasing the depth of sequencing. That
can be partially overcome by improving
the sample preparation. Moreover, their
work revealed two advantages of NGS-
WG: first, viruses were identified that
would not have been routinely queried
by PCR assays for known pathogens (for
example astrovirus MLB2 in plasma). Also
WG-NGS enabled determination of virus
subtype or variant strains of rhinovirus,
bocavirus and HHV-6, even on the basis
of a few reads, without sequencing most
of the viral genome. Microbial and DNA
virus loads in plasma were also followed
efficiently after immunosuppressive ther-
apy (De Vlaminck et al., 2013). In the
field of bacteriology, most studies have
dealt with sequencing of clinical iso-
lates cultured in vitro, but good results
have been obtained by direct sequenc-
ing from clinical samples, for example for
the diagnosis of tuberculosis lesions (Chan
et al., 2013), fecal samples from diarrheic
patients (Loman et al., 2013), or urinary
samples from patients with suspected uri-
nary tract infections (Hasman et al., 2014).
Another advantage of the technique is its
capacity to identify co-infections, which is
of great help to adapt therapeutics.
Developing a WG-NGS diagnostic
pipeline critically relies on two partly
interdependent criteria: time to results
and database exhaustiveness. Indeed, some
sequence knowledge is necessary to design
primers for PCR, but the whole genome
sequence does not need to be known.
Indeed this is also the case for WG-NGS,
but lack of information regarding the
whole genome sequence and organiza-
tion will have an impact on sensitivity
(some useful reads being at risk of not
being properly identified). As the growth
of databases is very rapid, being fueled
by the development of NGS as a stan-
dard tool, such limits will not last long.
Also, the requirements are not the same
for pathogen discovery, when the range
of detection should typically include
the unknown, and medical diagnosis. In
this latter case, it is more important to
screen samples against a curated database
of known pathogens that could be of
interest for the physicians. Typical blast
analysis of hundreds of million of reads
after de novo assembly into larger con-
tigs against the whole NCBI databases
using relaxed criteria, which is classical
in pathogen discovery, is too time- and
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resource-consuming to be used in diag-
nostics. By contrast, stringent mapping of
non-assembled reads on a comprehensive
database of pathogens, together with the
progressive increase of read length per-
mitted by the evolution of sequencers,
speeds up the overall process down to a
few hours. Time from sample to results
can thus be 2 days or even less, which
is useful for some indications. Indeed,
this time to results still remains much
longer than the few hours needed for
some PCRs and the needs of critical care
(<8 h).
The question is probably not if, but
rather when, WG-NGS will become a
routine test in diagnostics of infectious
diseases. This development will require
improvement in sample preparation,
availability of sequencers in central lab-
oratories and validated pipelines for read
sorting and taxonomic assignation. There
is no doubt that such an opportunity will
sooner than later profoundly change the
routine laboratory practice together with
the means of conducting microbiological
diagnosis.
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